This information is updated frequently and will continue to evolve. We will keep you posted of significant developments as they occur. If you have any questions on these materials, please contact Joel Kopperud at joel.kopperud@ciab.com.

The Council’s Positions

The Council’s largest priority in this fight is the preservation of Employer-Sponsored Insurance. Employer-Sponsored Insurance (ESI) is the most common type of health coverage in the United States, with more than 181 million Americans depending on it. But some in Congress want to tax employees on the cost of their health care benefits.

Imposing a tax on employer-sponsored health plans is a dangerous policy experiment that could significantly erode employer-sponsored health coverage. Any cap on the tax exclusion is a direct tax on employees and the middle class.

Click here to see our full page on ESHI.

The Council is also continuing to fight against the Cadillac Tax. The Affordable Care Act includes a 40% excise tax on employer-sponsored health plans with annual premiums exceeding $10,200 for individuals or $27,500 for families (the amount exceeding the threshold is taxed at 40%). Most predictions indicate that a significant number of group health plans would trigger the 40 percent excise tax if there aren’t any adjustments made to the threshold. This has been dubbed the “Cadillac Tax” referring to high-cost health plans.

You can learn more about the Cadillac Tax here.

Get the Latest

See more by reading the latest Healthcare in Transition newsletter, below.

Questions?

Please contact Joel Wood at joel.wood@ciab.com or Joel Kopperud at joel.kopperud@ciab.com with any questions.

Healthcare in Transition Spotlight

The Next Step in 1332 Section Waiver Changes
Healthcare In Transition | Dec. 5, 2018 | Healthcare

December 5, 2018 The Departments of Treasury and Health and Human Services recently released four new Section 1332 “waiver concepts” to illustrate how states might take advantage of recently-released guidance

Tech Giants Poised to Shift Healthcare Landscape
Healthcare In Transition | Dec. 5, 2018 | Healthcare

December 5, 2018 Tech companies are banging down the doors of the healthcare industry, infiltrating different pieces of a complicated system in an effort to inject innovation into care delivery

An Update on Prescription Drug Legislation
Healthcare In Transition | Dec. 5, 2018 | Healthcare

December 5, 2018 Legislative and regulatory efforts to reduce drug costs is a top priority for both Democrats and Republicans in the next Congress, and it’s one of the few

How Disruptive is Medicare for All?
Healthcare In Transition | Dec. 5, 2018 | Healthcare, Single Payer

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund

1332 Section Waiver Changes
Healthcare In Transition | Nov. 8, 2018 | ACA, Healthcare

November 8, 2018 The Department of Health and Human Services (HHS) released new guidance on Section 1332 State Innovation Waivers under the ACA with the goal of reducing burdens on

ACA Reform Legislation Tracker as of October 2018
Healthcare In Transition | Nov. 8, 2018 | ACA, Healthcare

November 8, 2018 Our legal team at Steptoe & Johnson tracks healthcare reform bills as they are introduced in Congress. Check out the most recent updates as of October on

Drug Pricing on TV
Healthcare In Transition | Nov. 8, 2018 | Healthcare

November 8, 2018 The CMS proposed that drug manufacturers be required to disclose the list prices of drugs covered by Medicare or Medicaid in TV ads. In particular, manufacturers would

Pharmacy Supply Chain: What You Need to Know
Healthcare In Transition | Nov. 8, 2018 | Drug Pricing

November 8, 2018 Despite the Trump administration’s push to lower drug prices, costs have not yet decreased. Lack of consensus regarding how to approach the complex pharmacy supply chain has

Midterm Implications for Healthcare
Healthcare In Transition | Nov. 8, 2018 | ACA, Government Affairs, Healthcare

November 8, 2018 Healthcare proved significant to voters on Tuesday, but it was not quite pivotal. Democrats scored a majority in the House, while Republicans expanded their majority in the

Resources

The Next Step in 1332 Section Waiver Changes

December 5, 2018 The Departments of Treasury and Health and Human Services recently released four new Section 1332 “waiver concepts” to illustrate how states might take advantage of recently-released guidance

IRS Extends Certain Due Dates for ACA Information Reporting to Individuals

December 5, 2018 The Internal Revenue Service (IRS) recently issued a notice extending certain due dates for 2018 ACA information reporting to individuals under Sections 6055 and 6056 of the

Tech Giants Poised to Shift Healthcare Landscape

December 5, 2018 Tech companies are banging down the doors of the healthcare industry, infiltrating different pieces of a complicated system in an effort to inject innovation into care delivery

An Update on Prescription Drug Legislation

December 5, 2018 Legislative and regulatory efforts to reduce drug costs is a top priority for both Democrats and Republicans in the next Congress, and it’s one of the few

How Disruptive is Medicare for All?

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund

1332 Section Waiver Changes

November 8, 2018 The Department of Health and Human Services (HHS) released new guidance on Section 1332 State Innovation Waivers under the ACA with the goal of reducing burdens on

ACA Reform Legislation Tracker as of October 2018

November 8, 2018 Our legal team at Steptoe & Johnson tracks healthcare reform bills as they are introduced in Congress. Check out the most recent updates as of October on

Drug Pricing on TV

November 8, 2018 The CMS proposed that drug manufacturers be required to disclose the list prices of drugs covered by Medicare or Medicaid in TV ads. In particular, manufacturers would

Pharmacy Supply Chain: What You Need to Know

November 8, 2018 Despite the Trump administration’s push to lower drug prices, costs have not yet decreased. Lack of consensus regarding how to approach the complex pharmacy supply chain has

Midterm Implications for Healthcare

November 8, 2018 Healthcare proved significant to voters on Tuesday, but it was not quite pivotal. Democrats scored a majority in the House, while Republicans expanded their majority in the